Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 - 2025

The "Pharmacovigilance Market by Clinical Trial Phase, by Service Provider, by Method, and by End-User: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

The report covers a forecast and an analysis of the pharmacovigilance market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion).

The study includes the drivers and restraints of the pharmacovigilance market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the pharmacovigilance market on a global level.

In order to give the users of this report a comprehensive view of the pharmacovigilance market, we have included a competitive landscape and an analysis of Porter's Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, product, and regional expansion of major participants involved in the market.

The study provides a decisive view on the pharmacovigilance market by segmenting it on the basis of clinical trial phase, service provider, method, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., UK, Germany, France, China, Japan, India, Brazil, etc.

Some key players in the global pharmacovigilance market include as F. Hoffmann-La Roche, Cognizant, Pharmaceutical Clinical Trial Phase Development, Bristol-Myers Squibb, Covance, ICON, Accenture, Pfizer, Clinquest Group, Novartis International, GlaxoSmithKline, PAREXEL International, iGATE Corporation, iMEDGlobal Corporation, and inVentiv Health.

Market Dynamics

Drivers

• Increasing Consumption of Drugs Fuels the Continuous Drug Event Monitoring Demand

• The Rising Adoption of Outsourcing Services

Restraints

• High Risk Associated With Data Security in Pharmacovigilance Outsourcing Opportunities

• Huge Scope for the Rapid Growth of Pharmacovigilance Market in Emerging Economies

This report segments the global pharmacovigilance market as follows:

Clinical Trial Phase Analysis

• Pre-Clinical

• Phase I

• Phase II

• Phase III

• Phase IV

Service Provider Analysis

• In-House

• Contract Outsourcing

Method Analysis

• Spontaneous Reporting

• Intensified ADR Reporting

• Targeted Spontaneous Reporting

• Cohort Event Monitoring

• EHR Mining

End-user Analysis

• Hospitals

• Research Organizations

• Industries

Companies Profiled 

• F. Hoffmann-La Roche

• Cognizant

• Pharmaceutical Clinical Trial Phase Development

• Bristol-Myers Squibb

• Covance

• ICON

• Accenture

• Pfizer

• Clinquest Group

• Novartis International

• GlaxoSmithKline

• PAREXEL International

• iGATE Corporation

• iMEDGlobal Corporation

• inVentiv Health